普米克气雾剂治疗儿童哮喘的疗效观察

The therapeutic effects observation on treating asthma of children by pulmicort aerosol

目的 :观察普米克气雾剂治疗儿童哮喘的疗效。方法 :吸入气雾剂最上为 2 0 0ug/d ,最大剂量 80 0ug/d ,平均 4 0 0ug/d。喘息发作时加用β2 受体激动剂。结果 :应用肺功能检测仪对 12 5例儿童哮喘患儿普米克气雾剂吸入治疗前后最大呼气峰流速 (PEF) ,1s最大呼气流量 (FEV1)和肺活量(FVC)的指标检测 ,其中FEV(t =9.85P <0 .0 1) ,PEF(t=8.87P <0 .0 1) ,FVC(T =8.15p <0 .0 1) ,/FVC % (t=9.81P <0 .0 1)具有显著性差异。结论 :普米克气雾剂是一种临床疗效高 ,副作用小的抗哮喘药物。

Objective: Observating therapeutic effects ofpulmicort aerosol on treating asthma of children. Methods: Theminimal dosage of breathing aerosol is 200 u g/d, the maximalis 800 u g/d,the general is 400 u g/d. The 2 acceptorexcitomotory is used when asthma breaks out . Results: Themonitoring targets of PEF, FEV1, FVC use lungs functionmonitor instrument for 125 patients of children asthma beforeand after treating of breath pulmicort aerosol, their FEV1 (t=9.85 P<0.01) PEF(t=8.87 P<0.01) FVC(t=8.15 P<0.0l) FEV1/FVC%(t=9.81 P<:0.01) show singificant difference.Conclusion:Pulmicort aerosol is a high clinical therapeutic effective andlow vice functional antiasthma drug.